Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
Christie Lin, Tyler Bradshaw, Timothy Perk, et al.
Journal of Nuclear Medicine (2016) Vol. 57, Iss. 12, pp. 1872-1879
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Clinical PET Imaging in Prostate Cancer
Kathryn Wallitt, Sairah R. Khan, Suraiya Dubash, et al.
Radiographics (2017) Vol. 37, Iss. 5, pp. 1512-1536
Closed Access | Times Cited: 108
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial
Andrea B. Apolo, Rosa Nadal, Yusuke Tomita, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 8, pp. 1099-1109
Open Access | Times Cited: 80
Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT
Eric Rohren, Elba Etchebehere, John C. Araujo, et al.
Journal of Nuclear Medicine (2015) Vol. 56, Iss. 10, pp. 1507-1512
Open Access | Times Cited: 72
The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer
Iain Murray, Sarah Chittenden, Ana M. Denis-Bacelar, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. 11, pp. 1832-1844
Open Access | Times Cited: 71
Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer
Douglas G. McNeel, Jens C. Eickhoff, Laura E. Johnson, et al.
Journal of Clinical Oncology (2019) Vol. 37, Iss. 36, pp. 3507-3517
Open Access | Times Cited: 60
Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer
Samuli Arvola, Ivan Jambor, Anna Kuisma, et al.
EJNMMI Research (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 59
Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art
Raquel Pérez-López, Nina Tunariu, Anwar R. Padhani, et al.
Radiology (2019) Vol. 292, Iss. 2, pp. 273-286
Closed Access | Times Cited: 57
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach
Luca Filippi, Luca Urso, Francesco Bianconi, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 3, pp. 243-255
Closed Access | Times Cited: 17
Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone
Stephanie A. Harmon, Timothy Perk, Christie Lin, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 24, pp. 2829-2837
Open Access | Times Cited: 56
Automated classification of benign and malignant lesions in 18F-NaF PET/CT images using machine learning
Timothy Perk, Tyler Bradshaw, Song Chen, et al.
Physics in Medicine and Biology (2018) Vol. 63, Iss. 22, pp. 225019-225019
Closed Access | Times Cited: 51
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer
Douglas G. McNeel, Hamid Emamekhoo, Jens C. Eickhoff, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e008067-e008067
Open Access | Times Cited: 16
18F-Sodium fluoride PET-CT visualizes disease activity in chronic nonbacterial osteitis in adults
Anne T Leerling, Frits Smit, Zita Spӓth, et al.
JBMR Plus (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 5
18F-NaF PET/CT IMAGING IN FIBROUS DYSPLASIA OF BONE
Georgios Z. Papadakis, Georgios C. Manikis, Apostolos H. Karantanas, et al.
Journal of Bone and Mineral Research (2019) Vol. 34, Iss. 9, pp. 1619-1631
Open Access | Times Cited: 38
EARL compliance measurements on the biograph vision Quadra PET/CT system with a long axial field of view
George Prenosil, Michael Hentschel, Thilo Weitzel, et al.
EJNMMI Physics (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Daniel M. Girardi, Scot A. Niglio, Amir Mortazavi, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 7, pp. 1353-1362
Open Access | Times Cited: 20
Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical Therapy
Victor Santoro-Fernandes, Brayden Schott, Amy J. Weisman, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.267809-jnumed.124.267809
Closed Access
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging
Gurdip Azad, Benjamin Taylor, Adrian Green, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2018) Vol. 46, Iss. 4, pp. 821-830
Open Access | Times Cited: 36
3D skeletal uptake of 18F sodium fluoride in PET/CT images is associated with overall survival in patients with prostate cancer
Sarah Lindgren Belal, May Sadik, Reza Kaboteh, et al.
EJNMMI Research (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 35
Application of PET Tracers in Molecular Imaging for Breast Cancer
Jorianne Boers, Erik F. J. de Vries, Andor W. J. M. Glaudemans, et al.
Current Oncology Reports (2020) Vol. 22, Iss. 8
Open Access | Times Cited: 32
Therapy assessment of bone metastatic disease in the era of 223radium
Elba Etchebehere, Ana Emília Brito, Alireza Rezaee, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. S1, pp. 84-96
Closed Access | Times Cited: 33
Toward a Droplet-Based Single-Cell Radiometric Assay
Maria Elena Gallina, Tae Jin Kim, Mark Shelor, et al.
Analytical Chemistry (2017) Vol. 89, Iss. 12, pp. 6472-6481
Open Access | Times Cited: 32
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study
Hebert Alberto Vargas, Gem Kramer, Andrew M. Scott, et al.
Journal of Nuclear Medicine (2018) Vol. 59, Iss. 10, pp. 1516-1523
Open Access | Times Cited: 25
Quantitative Test–Retest Measurement of 68Ga-PSMA-HBED-CC in Tumor and Normal Tissue
Janet H. Pollard, Caleb Raman, Yousef Zakharia, et al.
Journal of Nuclear Medicine (2019) Vol. 61, Iss. 8, pp. 1145-1152
Open Access | Times Cited: 25
Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide
Christos E. Kyriakopoulos, Elisabeth I. Heath, Anna C. Ferrari, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 31, pp. 3662-3671
Open Access | Times Cited: 22
Using stacked deep learning models based on PET/CT images and clinical data to predict EGFR mutations in lung cancer
Song Chen, Xiangjun Han, Guangwei Tian, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top